Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marshall Z. Schwartz is active.

Publication


Featured researches published by Marshall Z. Schwartz.


Journal of Laparoendoscopic & Advanced Surgical Techniques | 2011

Early Experience with Single-Incision Thoracoscopic Surgery in the Pediatric Population

Rajeev Prasad; L. Grier Arthur; Shaheen J. Timmapuri; Marshall Z. Schwartz; Timothy Fairbanks; Kim G. Mendelson; Keith A. Thatch; Matthew Moront

INTRODUCTIONnSingle-incision pediatric endosurgery is gaining popularity in children. We have recently applied the single-incision approach for thoracoscopic procedures. We report our initial experience with single-incision thoracoscopic surgery in the pediatric population.nnnMETHODSnA retrospective chart review of the first 10 single-incision thoracoscopic operations done at our institution was conducted. The patients mean age and weight and the median operative time, postoperative length of stay, and time until discontinuation of chest tubes were determined.nnnRESULTSnThe 10 procedures were performed in eight patients (two patients each had bilateral procedures). The procedures performed included wedge resection and mechanical pleurodesis for spontaneous pneumothorax (nu2009=u20097), wedge biopsies for lymphoma (nu2009=u20091) and chronic granulomatous disease (nu2009=u20091), and resection of an apical extrapulmonary neuroblastoma (nu2009=u20091). All of the procedures were completed without intraoperative complication or significant blood loss. In each case, multiple trocars and/or unsheathed instruments were passed through a single small incision, which was subsequently used for the chest tube(s). The mean patient age was 13.5 years (range 3-18 years). The mean weight was 47 kilograms (range 16-63u2009kg). The median operative time was 64 minutes (range 50-201 minutes). The median postoperative length of stay was 7 days (range 3-19 days). The median time until chest tube removal was 3 days (range 2-15 days). The mean follow-up was 7 months (range 3-12 months). One patient developed a recurrent pneumothorax and persistent air leak after having undergone a wedge resection and pleurodesis for a spontaneous pneumothorax and required a reoperation.nnnCONCLUSIONnSingle-incision thoracoscopic surgery is a feasible alternative to the traditional multiple-incision approach in the pediatric population. The in-line positioning of the camera and instruments often proves to be an advantage rather than a hindrance.


Pediatric and Developmental Pathology | 2006

Study of an ovarian sclerosing stromal tumor presenting as vaginal bleeding in a 7-month-old.

Odette R. Hall; Judy Mae Pascasio; Jennifer J.D. Morrissette; Christopher Newton; Marshall Z. Schwartz; Jean-Pierre de Chadarévian

This communication describes the histological, immunohistochemical, ultrastructural, and cytogenetic study of an ovarian sclerosing stromal tumor resected from a 7-month-old girl who presented with vaginal bleeding. The tumor is very rare, its pathogenesis is not clear, and its hormonal activity has been subject to debate. In addition, it has been rarely seen in children and never in infants, with the youngest patient reported being 10 years of age. Histological study of the tumor showed a process of multinodular asynchronous growth followed by gradual loss of cells, hyalinization, and eventual transformation into corpora albicantia–like structures, thus indicating that the process may be more akin to an ovarian nodular follicular hyperplasia than to a classical neoplasm. The study also documented an elevated proliferative MIB-1 index in the process, which had not been investigated in earlier reports, and illustrated the immunohistochemical reactivity of some of its stromal cells to progesterone receptors.


Pediatric and Developmental Pathology | 2009

Terminal Ileal Atresia, Total Colonic Aganglionosis, and Thrombophilia

Jean-Pierre de Chadarévian; Shondell M. Bouie; Marie E. Peddinghaus; Lori R. Luck; Marshall Z. Schwartz; Rajeev Prasad; Eric N. Faerber

Inherited thrombophilia, a predisposition for a hypercoagulable state, has been associated with cases of intestinal atresia. In this communication, we report a case of terminal ileal atresia and total colonic aganglionosis (Hirschsprungs disease), a rarely documented association, in a neonate who seemed to have a hypercoagulable state. The case stresses the need for recognition of this sequence of events in order to achieve optimal management.


Journal of The American College of Surgeons | 2000

Leptin: a new growth factor for the small intestine

Karim Alavi; Marshall Z. Schwartz; Rajeev Prasad; Vicky L. Funanage

PURPOSEnThis study was designed to evaluate the potential growth factor effects of systemic administration of leptin on mucosal mass and absorptive function in normal rat intestine.nnnMETHODSnTwenty male Sprague-Dawley rats underwent placement of a jugular venous catheter connected to a subcutaneous osmotic pump designed to deliver its contents at a constant rate. The rats were divided into 4 groups (n = 5 per group) based on the contents of the osmotic pump: group 1, 0.1% bovine serum albumin; group 2, leptin, 6.25 microgram/kg/d; Group 3, leptin, 18.75 microgram/kg/d; Group 4, leptin, 43.75 microgram/kg/d. After a 14-day infusion, [(14)C] galactose and [(14)C] glycine absorption were determined using a closed, recirculation technique. DNA content was determined from mucosal biopsies. Total RNA was extracted from mucosal samples, reverse transcribed, and amplified via polymerase chain reaction for the following primer pairs: sodium/glucose cotransporter (SGLT-1), fructose transporter (GLUT-5), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, internal standard). Statistical analysis was performed by analysis of variance and expressed as mean plus minus SEM.nnnRESULTSnSystemic administration of increasing doses of leptin enhanced DNA content when compared with the appropriate control (group 2, 1.06 plus minus 0.04 [P <.05]; group 3, 1.1 plus minus 0.05 [P <.01]; and group 4, 1.07 plus minus 0.06 [P <.05]. Leptin enhanced mucosal absorptive function (galactose: group 2, 2.31 plus minus 0.15 [P <.01]; group 3, 2.71 plus minus 0.06 [P <.01]; group 4, 2.19 plus minus 0.28 [P <.05]; glycine: group 2, 2.34 plus minus 0.31 [P <.05]; group 3, 3.32 plus minus 0.14 [P <.01]; group 4, 3.1 plus minus 0.27 [P <.01]) in the normal intestine when compared with the appropriate control animals. Also, leptin enhanced the gene expression of the carbohydrate transporters when compared with the appropriate control rats.nnnCONCLUSIONSnThese data show that systemic leptin administration enhances mucosal mass and absorptive function in normal rat intestine. Thus, leptin appears to be a growth factor for normal small intestine and may play a role in patients who acquire intestinal dysfunction.


Journal of Pediatric Surgery | 2002

Leptin: A new growth factor for the small intestine

Karim Alavi; Marshall Z. Schwartz; Rajeev Prasad; Darlise O'Connor; Vicky L. Funanage


Gastroenterology | 1998

Glucagon-like peptide-2 enhances intestinal function following massive small bowel resection

I. Kato; K. Alavi; Dahong Yu; Marshall Z. Schwartz


Gastroenterology | 2000

Novel use of hepatocyte growth factor in the treatment of inflammatory bowel disease

Karim Alavi; Marshall Z. Schwartz; Rajeev Prasad; Juan P. Palazzo


Journal of The American College of Surgeons | 2008

The 59th Volume of the Surgical Forum is Dedicated to Patricia K Donahoe, MD, FACS

Marshall Z. Schwartz


Journal of The American College of Surgeons | 2007

A novel therapeutic agent in the management of inflammatory bowel disease

Edward Y. Yoo; Duane S. Duke; Marian M. Haber; Marshall Z. Schwartz


Gastroenterology | 2003

Hepatocyte growth factor: A novel approach to the management of inflammatory bowel disease

Lindsay G. Arthur; Keith A. Kuenzler; Marshall Z. Schwartz

Collaboration


Dive into the Marshall Z. Schwartz's collaboration.

Top Co-Authors

Avatar

Rajeev Prasad

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Karim Alavi

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Vicky L. Funanage

Alfred I. duPont Hospital for Children

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hugh Wang

Alfred I. duPont Hospital for Children

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge